The panel outperformed AFP in the diagnosis of early-stage HCC (AUROC = 0.85–0.91 for P5 and 0.54–0.59 for AFP, according to different cutoff values and different validation cohorts). This evidence concerns the gene AFP and hepatocellular carcinoma.